Taking on Diabetes to Advance You (TODAY)
Overview
The program will consist of diabetes self-management sessions, led by an occupational therapist. The sessions will be held in an individualized format. Sessions will focus on diabetes education, self-management education, and education on behaviors and adaptive techniques to optimize participation in daily life with type II diabetes. As occupational therapists, the investigators and facilitator, aim to focus on establishing healthy habits, roles, and routines for individuals with type 2 diabetes.
Full Title of Study: “Taking on Diabetes to Advance You”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: N/A
- Intervention Model: Single Group Assignment
- Primary Purpose: Prevention
- Masking: None (Open Label)
- Study Primary Completion Date: April 24, 2018
Interventions
- Behavioral: Taking on Diabetes to Advance You (TODAY) Project
- This is an individualized educational intervention with activity components designed to assist in modifying habits, roles, and routines to promote healthy lifestyle patterns for individuals with type 2 diabetes.
Arms, Groups and Cohorts
- Other: TODAY Project
- All participants will attend individualized self-management sessions led by an occupational therapist. The classes will focus on promoting modifying daily activities, habits, roles, and routines to promote healthy lifestyles for individuals with type 2 diabetes.
Clinical Trial Outcome Measures
Primary Measures
- The Diabetes Self-Management Questionnaire
- Time Frame: through the end of the intervention period, up to one year
- 16-item self-report to assess self-care activities associated with diabetes
Participating in This Clinical Trial
Inclusion Criteria
- type 2 diabetes – 18 or older – patient at the Family Medicine Center in Fort Collins Exclusion Criteria:
- reading level below 6th grade – inability to understand written or verbal instructions regarding questionnaires
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Arlene Schmid
- Provider of Information About this Clinical Study
- Sponsor-Investigator: Arlene Schmid, Associate Professor, Co-Investigator – Colorado State University
- Overall Official(s)
- Matt Malcolm, PhD, Principal Investigator, Colorado State University
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.